Published in Hum Genet on January 01, 1984
p107 is a suppressor of retinoblastoma development in pRb-deficient mice. Genes Dev (1998) 2.53
Mechanisms of p53 loss in human sarcomas. Proc Natl Acad Sci U S A (1990) 2.03
Chromosome 6p amplification and cancer progression. J Clin Pathol (2006) 1.42
Saccharomyces cerevisiae as a model system to define the chromosomal instability phenotype. Mol Cell Biol (2005) 1.24
Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma. Am J Hum Genet (1997) 1.07
Elevation of cell cycle control proteins during spontaneous immortalization of human keratinocytes. Mol Biol Cell (1993) 1.01
Cytogenetic investigations of solid tumours of children. Arch Dis Child (1988) 0.81
Chromosomes of metastatic retinoblastoma. Arch Dis Child (1987) 0.75
Multiple changes in oncogenes and tumor suppressor genes in human retinoblastoma. Trans Am Ophthalmol Soc (1996) 0.75
Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature (1983) 11.57
Separation of cells by velocity sedimentation. J Cell Physiol (1969) 8.73
Introduction of a selectable gene into primitive stem cells capable of long-term reconstitution of the hemopoietic system of W/Wv mice. Cell (1985) 6.88
Motion parallax as an independent cue for depth perception. Perception (1979) 4.98
Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA (2001) 4.75
Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency. Cell (1986) 4.68
Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol (1985) 4.61
The identification in adult bone marrow of pluripotent and restricted stem cells of the myeloid and lymphoid systems. J Exp Med (1977) 4.44
The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat Neurosci (1999) 4.35
Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype. Am J Pathol (2000) 4.19
Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line. Science (1995) 4.19
History of the enzyme nomenclature system. Bioinformatics (2000) 3.90
The scid mutation in mice causes a general defect in DNA repair. Nature (1990) 3.85
Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid). J Immunol (1985) 3.69
Decrease in net stool output in cholera during intestinal perfusion with glucose-containing solutions. N Engl J Med (1968) 3.57
beta-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell (1995) 3.33
Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome. Nat Genet (1993) 3.08
Migration and stopover in a small pelagic seabird, the Manx shearwater Puffinus puffinus: insights from machine learning. Proc Biol Sci (2009) 3.03
Multiple regulatory elements in the intergenic region between the alpha-fetoprotein and albumin genes. Mol Cell Biol (1986) 2.83
Initiation of antibody production to sheep erythrocytes in vitro: replacement of the requirement for T-cells with a cell-free factor isolated from cultures of lymphoid cells. J Immunol (1972) 2.83
Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene. Mol Cell Biol (1992) 2.78
Warm-coding deficits and aberrant inflammatory pain in mice lacking P2X3 receptors. Nature (2000) 2.73
High-resolution mapping of mammalian genes by in situ hybridization to free chromatin. Proc Natl Acad Sci U S A (1992) 2.72
The scid defect affects the final step of the immunoglobulin VDJ recombinase mechanism. Cell (1988) 2.71
Functional status of cells from lymphoid and myeloid tissues in mice with severe combined immunodeficiency disease. J Immunol (1984) 2.56
Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia. Nat Genet (2001) 2.55
Oral maintenance therapy for cholera in adults. Lancet (1968) 2.53
pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. Genes Dev (1996) 2.47
Use of minor tranquilizers and antidepressant medications by depressed outpatients: results from the medical outcomes study. Am J Psychiatry (1994) 2.45
Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition. Proc Natl Acad Sci U S A (1985) 2.44
B-lymphocyte subpopulations in the mouse. Organ distribution and ontogeny of immunoglobulin-synthesizing and of mitogen-sensitive cells. Transplant Rev (1975) 2.25
Genetic origin of mutations predisposing to retinoblastoma. Science (1985) 2.22
Multicenter evaluation of the Cepheid Xpert methicillin-resistant Staphylococcus aureus (MRSA) test as a rapid screening method for detection of MRSA in nares. J Clin Microbiol (2009) 2.20
Retrovirus transfer of a bacterial gene into mouse haematopoietic progenitor cells. Nature (1983) 2.20
Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer. Gene Ther (1999) 2.17
Direct transcriptional repression by pRB and its reversal by specific cyclins. Mol Cell Biol (1995) 2.13
Repair of potentially lethal damage in x-irradiated HeLa cells. Radiat Res (1966) 2.09
Bacteria lacking a multidrug pump: a sensitive tool for drug discovery. Proc Natl Acad Sci U S A (1998) 2.01
Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. I. Study design and results of the first year of observation. Bull World Health Organ (1969) 2.00
Mutations in the RB1 gene and their effects on transcription. Mol Cell Biol (1989) 2.00
Identification of germline and somatic mutations affecting the retinoblastoma gene. Science (1988) 2.00
Allograft immunity in the mouse. II. Physical studies of the development of cytotoxic effector cells from their immediate progenitors. J Immunol (1973) 1.89
Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the beta-amyloid precursor protein. Neuroscience (1999) 1.88
Quantitative studies of the activation of cytotoxic lymphocyte precursor cells. Immunol Rev (1977) 1.87
Modulation of gene expression in multiple hematopoietic cell lineages following retroviral vector gene transfer. Proc Natl Acad Sci U S A (1987) 1.86
Isolation of scid pre-B cells that rearrange kappa light chain genes: formation of normal signal and abnormal coding joins. EMBO J (1989) 1.86
Hypertensive cardiovascular damage in patients with primary autonomic failure. Lancet (2000) 1.86
CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines. Cancer Res (1994) 1.76
Exploratory analysis of the safety climate and safety behavior relationship. J Safety Res (2004) 1.74
Tissue-specific transcription of the mouse alpha-fetoprotein gene promoter is dependent on HNF-1. Mol Cell Biol (1989) 1.74
Water and sodium absorption in the human intestine. J Physiol (1968) 1.72
Somatic inactivation of genes on chromosome 13 is a common event in retinoblastoma. Nature (1983) 1.71
A quantitative assay for the progenitors of bone marrow-associated lymphocytes. J Exp Med (1972) 1.69
Preferential germline mutation of the paternal allele in retinoblastoma. Nature (1989) 1.69
Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. J Pharmacol Exp Ther (2001) 1.65
Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience (1989) 1.64
Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles. J Pharmacol Exp Ther (1999) 1.63
A model of human acute lymphoblastic leukemia in immune-deficient SCID mice. Science (1989) 1.60
Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1. Hum Mol Genet (2001) 1.58
Quantitative studies on the precursors of cytotoxic lymphocytes. I. Characterization of a clonal assay and determination of the size of clones derived from single precursors. J Immunol (1977) 1.57
Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation. Clin Cancer Res (1996) 1.57
Development of retinoblastoma in the absence of telomerase activity. J Natl Cancer Inst (1996) 1.57
Characterization of tobacco products: a comparative study of the tar, nicotine, and carbon monoxide yields of cigars, manufactured cigarettes, and cigarettes made from fine-cut tobacco. Prev Med (1985) 1.57
Constraints of interest: lessons at the Hospital for Sick Children. CMAJ (1998) 1.54
Frequency of somatic and germ-line mosaicism in retinoblastoma: implications for genetic counseling. Am J Hum Genet (1998) 1.54
Actions taken to cope with depression at different levels of severity: a community survey. Psychol Med (2004) 1.52
Retinoma: spontaneous regression of retinoblastoma or benign manifestation of the mutation? Br J Cancer (1982) 1.52
Tobacco consumption declining faster in Canada than in the US. Am J Public Health (1991) 1.50
Prostate cancer abdominal metastases detected with indium-111 capromab pendetide. J Nucl Med (1998) 1.49
Cost comparison of molecular versus conventional screening of relatives at risk for retinoblastoma. Am J Hum Genet (1996) 1.49
Differentiation of rosette-forming cells from myeloid stem cells. J Immunol (1970) 1.49
Brca1 required for T cell lineage development but not TCR loci rearrangement. Nat Immunol (2000) 1.48
Homogeneity of antibody-producing cells as analysed by their buoyant density in gradients of Ficoll. Immunology (1970) 1.45
Using the rat as a cholera "model". Nature (1968) 1.45
Expression of human adenosine deaminase in murine haematopoietic progenitor cells following retroviral transfer. Nature (1986) 1.44
Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br J Pharmacol (1997) 1.44
The retinoblastoma protein and cell cycle regulation. Trends Genet (1992) 1.42
The genetics of retinoblastoma. Relevance to the patient. Pediatr Clin North Am (1991) 1.42
Cumulative effect of phosphorylation of pRB on regulation of E2F activity. Mol Cell Biol (1999) 1.42
Public nutrition. Am J Clin Nutr (1996) 1.41
In vivo requirement for a radiation-resistant cells in the immune response to sheep erythrocytes. J Exp Med (1971) 1.41
Crystal structure and thermodynamic analysis of human brain fatty acid-binding protein. J Biol Chem (2000) 1.38
Identification and sequencing of a putative variant of proopiomelanocortin in human epidermis and epidermal cells in culture. J Invest Dermatol (1998) 1.38
Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach. J Pharmacol Exp Ther (1995) 1.37